; and . 502. Amendments to the Monitoring the Future survey Beginning on January 1, 2024, the Director of the National Institute on Drug Abuse, in collaboration with the Secretary and the Director of the National Institutes of Health, shall require the survey funded by the National Institute on Drug Abuse and titled Monitoring the Future to include— (1) indicators to measure the use of, perception of harm of, and access to counterfeit or synthetic opioids among youth; and (2) where applicable, indicators to measure the extent to which respondents are aware of the counterfeit or synthetic nature of any opioids used or encountered by such respondents. 503. Youth Risk Behavior Survey Beginning on January 1, 2024, the Director of the Centers for Disease Control and Prevention shall require the data collection survey for the Youth Risk Behavior Surveillance System to include— (1) questions related to the use of, awareness regarding, and exposure to counterfeit or synthetic opioids, including fentanyl; and (2) where applicable, indicators to measure the extent to which respondents are aware of the counterfeit or synthetic nature of any opioids used or encountered by such respondents. 504. Evaluation of the effectiveness and reach of the State Unintentional Drug Overdose Reporting System (a) Evaluation Beginning on or after January 1, 2024, the Director of the Centers for Disease Control and Prevention shall conduct an evaluation determining the effectiveness of the State Unintentional Drug Overdose Reporting System in collecting and reporting data regarding— (1) specific synthetic opioids causing or contributing to overdose and death among children, adolescents, and young adults